{"count": 15, "results": [{"_id": "37173537", "pmid": 37173537, "pmcid": "PMC10338407", "title": "Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease", "journal": "Pharm Res", "authors": ["Janetzki JL", "Pratt NL", "Ward MB", "Sykes MJ"], "date": "2023-05-12T00:00:00Z", "doi": "10.1007/s11095-023-03516-x", "meta_date_publication": "2023 May 12", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50272.543, "text_hl": "Statistical and molecular modelling analyses confirmed that the use of several registered drugs, including @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@acetylsalicylic acid@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ may be associated with inhibition of @GENE_GPX1 @GENE_281209 @@@Glutathione Peroxidase 1@@@ and @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@.", "citations": {"NLM": "Janetzki JL, Pratt NL, Ward MB, Sykes MJ. Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease Pharm Res. 2023 May 12;():. PMID: 37173537", "BibTeX": "@article{37173537, title={Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease}, author={Janetzki JL and Pratt NL and Ward MB and Sykes MJ}, journal={Pharm Res}}"}}, {"_id": "37995048", "pmid": 37995048, "title": "Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis.", "journal": "Drug Saf", "authors": ["Janetzki JL", "Sykes MJ", "Ward MB", "Pratt NL"], "date": "2023-11-23T00:00:00Z", "doi": "10.1007/s40264-023-01374-5", "meta_date_publication": "2023 Nov 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.086, "text_hl": "Signals of @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ development, as identified using initiation of @CHEMICAL_Tiotropium_Bromide @CHEMICAL_MESH:D000069447 @@@tiotropium@@@, were observed for @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (aSR 1.32, 95% CI 1.23-1.42) and @CHEMICAL_Naproxen @CHEMICAL_MESH:D009288 @@@naproxen@@@ (aSR 1.14, 95% CI 1.06-1.23). ", "citations": {"NLM": "Janetzki JL, Sykes MJ, Ward MB, Pratt NL. Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis. Drug Saf. 2023 Nov 23;():. PMID: 37995048", "BibTeX": "@article{37995048, title={Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis.}, author={Janetzki JL and Sykes MJ and Ward MB and Pratt NL}, journal={Drug Saf}}"}}, {"_id": "2439815", "pmid": 2439815, "title": "Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.", "journal": "J Cardiovasc Pharmacol", "authors": ["Schiess W", "Dorow P"], "date": "1986-01-01T00:00:00Z", "doi": "10.1097/00005344-198608006-00007", "meta_date_publication": "1986", "meta_volume": "8 Suppl 6", "meta_issue": "", "meta_pages": "S30-3", "score": 50064.715, "text_hl": "@CHEMICAL_bopindolol @CHEMICAL_MESH:C036007 @@@Bopindolol@@@, @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@, and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive lung disease@@@.", "citations": {"NLM": "Schiess W, Dorow P. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease. J Cardiovasc Pharmacol. 1986;8 Suppl 6():S30-3. PMID: 2439815", "BibTeX": "@article{2439815, title={Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.}, author={Schiess W and Dorow P}, journal={J Cardiovasc Pharmacol}, volume={8 Suppl 6}, pages={S30-3}}"}}, {"_id": "2871220", "pmid": 2871220, "title": "Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.", "journal": "Klin Wochenschr", "authors": ["Dorow P", "Schiess W"], "date": "1986-04-15T00:00:00Z", "doi": "10.1007/BF01728185", "meta_date_publication": "1986 Apr 15", "meta_volume": "64", "meta_issue": "8", "meta_pages": "366-9", "score": 50064.156, "text_hl": "@CHEMICAL_bopindolol @CHEMICAL_MESH:C036007 @@@Bopindolol@@@, @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@, and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive lung disease@@@.", "citations": {"NLM": "Dorow P, Schiess W. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease. Klin Wochenschr. 1986 Apr 15;64(8):366-9. PMID: 2871220", "BibTeX": "@article{2871220, title={Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.}, author={Dorow P and Schiess W}, journal={Klin Wochenschr}, volume={64}, number={8}, pages={366-9}}"}}, {"_id": "324487", "pmid": 324487, "title": "[Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].", "journal": "Arzneimittelforschung", "authors": ["Beil M", "Ulmer WT"], "date": "1977-02-01T00:00:00Z", "meta_date_publication": "1977 Feb", "meta_volume": "27", "meta_issue": "2", "meta_pages": "419-22", "score": 50062.85, "text_hl": "[Effects of a new cardioselective beta-adrenergic blocker (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) on airway resistance in @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive disease@@@ (author's transl)].", "citations": {"NLM": "Beil M, Ulmer WT. [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)]. Arzneimittelforschung. 1977 Feb;27(2):419-22. PMID: 324487", "BibTeX": "@article{324487, title={[Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].}, author={Beil M and Ulmer WT}, journal={Arzneimittelforschung}, volume={27}, number={2}, pages={419-22}}"}}, {"_id": "15881093", "pmid": 15881093, "title": "[What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?].", "journal": "Ter Arkh", "authors": ["Kozlova LI", "Aĭsanov ZR", "Chuchalin AG"], "date": "2005-01-01T00:00:00Z", "meta_date_publication": "2005", "meta_volume": "77", "meta_issue": "3", "meta_pages": "18-23", "score": 50058.465, "text_hl": "AIM: To show specific features of respiratory disoders in @SPECIES_9606 @@@patients@@@ with @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@ischemic heart disease@@@ (@DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@IHD@@@) and @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@ (@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@) taking @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for a long time. ", "citations": {"NLM": "Kozlova LI, Aĭsanov ZR, Chuchalin AG. [What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?]. Ter Arkh. 2005;77(3):18-23. PMID: 15881093", "BibTeX": "@article{15881093, title={[What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?].}, author={Kozlova LI and Aĭsanov ZR and Chuchalin AG}, journal={Ter Arkh}, volume={77}, number={3}, pages={18-23}}"}}, {"_id": "2873530", "pmid": 2873530, "title": "[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].", "journal": "Minerva Med", "authors": ["Giorgis GE", "Galietti F", "Miravalle C", "Barberis S", "Massaglia GM", "Onoscuri E"], "date": "1986-06-23T00:00:00Z", "meta_date_publication": "1986 Jun 23", "meta_volume": "77", "meta_issue": "26", "meta_pages": "1255-8", "score": 50057.965, "text_hl": "[Possibilities of using cardioselective beta blocking agents in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive bronchopneumopathies@@@].", "citations": {"NLM": "Giorgis GE, Galietti F, Miravalle C, Barberis S, Massaglia GM, Onoscuri E. [Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies]. Minerva Med. 1986 Jun 23;77(26):1255-8. PMID: 2873530", "BibTeX": "@article{2873530, title={[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].}, author={Giorgis GE and Galietti F and Miravalle C and Barberis S and Massaglia GM and Onoscuri E}, journal={Minerva Med}, volume={77}, number={26}, pages={1255-8}}"}}, {"_id": "339932", "pmid": 339932, "title": "Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.", "journal": "Br J Clin Pharmacol", "authors": ["Perks WH", "Chatterjee SS", "Croxson RS", "Cruickshank JM"], "date": "1978-02-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1978.tb01608.x", "meta_date_publication": "1978 Feb", "meta_volume": "5", "meta_issue": "2", "meta_pages": "101-6", "score": 50057.688, "text_hl": "Comparison of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Oxprenolol @CHEMICAL_MESH:D010096 @@@oxprenolol@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@ or @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and co-existent @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic airways obstruction@@@.", "citations": {"NLM": "Perks WH, Chatterjee SS, Croxson RS, Cruickshank JM. Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. Br J Clin Pharmacol. 1978 Feb;5(2):101-6. PMID: 339932", "BibTeX": "@article{339932, title={Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.}, author={Perks WH and Chatterjee SS and Croxson RS and Cruickshank JM}, journal={Br J Clin Pharmacol}, volume={5}, number={2}, pages={101-6}}"}}, {"_id": "14520850", "pmid": 14520850, "title": "[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].", "journal": "Ter Arkh", "authors": ["Kukes VG", "Ostroumova OD", "Mamaev VI", "Batutina AM", "Abakumov IuE", "Zykova AA"], "date": "2003-01-01T00:00:00Z", "meta_date_publication": "2003", "meta_volume": "75", "meta_issue": "8", "meta_pages": "43-7", "score": 50055.297, "text_hl": "CONCLUSION: The results of @CHEMICAL_Bisoprolol @CHEMICAL_MESH:D017298 @@@bisoprolol@@@ treatment are better than those of methoprolol and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with concomitant @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ and @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@.", "citations": {"NLM": "Kukes VG, Ostroumova OD, Mamaev VI, Batutina AM, Abakumov IuE, Zykova AA. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases]. Ter Arkh. 2003;75(8):43-7. PMID: 14520850", "BibTeX": "@article{14520850, title={[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].}, author={Kukes VG and Ostroumova OD and Mamaev VI and Batutina AM and Abakumov IuE and Zykova AA}, journal={Ter Arkh}, volume={75}, number={8}, pages={43-7}}"}}, {"_id": "2879733", "pmid": 2879733, "title": "Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.", "journal": "Eur J Clin Pharmacol", "authors": ["Dorow P", "Bethge H", "Tönnesmann U"], "date": "1986-01-01T00:00:00Z", "doi": "10.1007/BF00606650", "meta_date_publication": "1986", "meta_volume": "31", "meta_issue": "2", "meta_pages": "143-7", "score": 50055.023, "text_hl": "Effects of single oral doses of @CHEMICAL_Bisoprolol @CHEMICAL_MESH:D017298 @@@bisoprolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on airway function in nonasthmatic @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive lung disease@@@ and @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina pectoris@@@.", "citations": {"NLM": "Dorow P, Bethge H, Tönnesmann U. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. Eur J Clin Pharmacol. 1986;31(2):143-7. PMID: 2879733", "BibTeX": "@article{2879733, title={Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.}, author={Dorow P and Bethge H and Tönnesmann U}, journal={Eur J Clin Pharmacol}, volume={31}, number={2}, pages={143-7}}"}}]}